Global Patent Index - EP 3201225 A4

EP 3201225 A4 20180523 - METHODS AND COMPOSITIONS FOR TREATMENT OF CONDITIONS ASSOCIATED WITH ELEVATED TRIGLYCERIDES

Title (en)

METHODS AND COMPOSITIONS FOR TREATMENT OF CONDITIONS ASSOCIATED WITH ELEVATED TRIGLYCERIDES

Title (de)

VERFAHREN UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON ERKRANKUNGEN IM ZUSAMMENHANG MIT ERHÖHTEN TRIGLYCERIDEN

Title (fr)

MÉTHODES ET COMPOSITIONS POUR LE TRAITEMENT D'AFFECTIONS ASSOCIÉES À DES TRIGLYCÉRIDES ÉLEVÉS

Publication

EP 3201225 A4 20180523 (EN)

Application

EP 15848061 A 20151002

Priority

  • US 201462059682 P 20141003
  • US 2015053700 W 20151002

Abstract (en)

[origin: WO2016054494A1] Methods and compositions for reducing one or more of triglyceride levels, total cholesterol levels and LDL cholesterol levels in a subject are provided. The methods include administering a fragment of ANGPTL8 to a subject having or at risk of developing elevated triglyceride levels, elevated total cholesterol levels and/or elevated LDL cholesterol levels.

IPC 8 full level

C07K 14/575 (2006.01); A61K 38/22 (2006.01); A61P 3/04 (2006.01); A61P 3/06 (2006.01); A61P 3/10 (2006.01)

CPC (source: EP US)

A61K 38/22 (2013.01 - EP US); A61P 3/04 (2017.12 - EP US); A61P 3/06 (2017.12 - EP US); A61P 3/10 (2017.12 - EP US); C07K 14/575 (2013.01 - EP US); G01N 33/92 (2013.01 - EP US); C07K 2319/00 (2013.01 - EP US); C07K 2319/30 (2013.01 - EP US); C07K 2319/31 (2013.01 - EP US); C07K 2319/50 (2013.01 - EP US)

Citation (search report)

  • [X] ANONYMOUS: "UPI0001D3DA7B", 27 July 2011 (2011-07-27), XP055454807, Retrieved from the Internet <URL:http://www.uniprot.org/uniparc/UPI0001D3DA7B> [retrieved on 20180227]
  • [A] Y. WANG ET AL: "Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis", PROCEEDINGS NATIONAL ACADEMY OF SCIENCES PNAS, vol. 110, no. 40, 16 September 2013 (2013-09-16), US, pages 16109 - 16114, XP055360825, ISSN: 0027-8424, DOI: 10.1073/pnas.1315292110
  • [A] ZHANG REN ET AL: "Emerging roles of Lipasin as a critical lipid regulator", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ELSEVIER, AMSTERDAM, NL, vol. 432, no. 3, 13 February 2013 (2013-02-13), pages 401 - 405, XP028998183, ISSN: 0006-291X, DOI: 10.1016/J.BBRC.2013.01.129
  • See references of WO 2016054494A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

WO 2016054494 A1 20160407; AU 2015327900 A1 20170202; AU 2015327900 B2 20200430; CA 2954082 A1 20160407; EP 3201225 A1 20170809; EP 3201225 A4 20180523; EP 3201225 B1 20200819; EP 3822287 A1 20210519; ES 2819866 T3 20210419; JP 2017531613 A 20171026; JP 6680758 B2 20200415; US 10071139 B2 20180911; US 10702587 B2 20200707; US 2017143799 A1 20170525; US 2019060408 A1 20190228; US 2021015902 A1 20210121

DOCDB simple family (application)

US 2015053700 W 20151002; AU 2015327900 A 20151002; CA 2954082 A 20151002; EP 15848061 A 20151002; EP 20185093 A 20151002; ES 15848061 T 20151002; JP 2017500335 A 20151002; US 201515318937 A 20151002; US 201816056068 A 20180806; US 202016888249 A 20200529